|
Volumn 29, Issue 1-2, 1997, Pages 333-
|
Rapamycin and cyclosporine A treatment: A novel regimen to prevent chronic allograft rejection in sensitized hosts
a a b b b a a b,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
GAMMA INTERFERON;
INTERLEUKIN 12;
INTERLEUKIN 2;
MESSENGER RNA;
MONOCYTE CHEMOTACTIC PROTEIN 1;
RANTES;
RAPAMYCIN;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTERIOSCLEROSIS;
CELL INFILTRATION;
CELL PROLIFERATION;
CONFERENCE PAPER;
CORONARY ARTERY;
DRUG POTENTIATION;
GENE EXPRESSION;
GRAFT REJECTION;
HEART TRANSPLANTATION;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAPERITONEAL DRUG ADMINISTRATION;
MONONUCLEAR CELL;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SENSITIZATION;
ARTERIOSCLEROSIS;
CHEMOKINE CCL2;
CHRONIC DISEASE;
CYCLOSPORINE;
CYTOKINES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMANS;
IMMUNIZATION;
IMMUNOSUPPRESSIVE AGENTS;
POLYENES;
POSTOPERATIVE COMPLICATIONS;
RANTES;
SIROLIMUS;
TRANSCRIPTION, GENETIC;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0030947858
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00290-4 Document Type: Conference Paper |
Times cited : (6)
|
References (2)
|